$HIND

$HIND

$HIND

$HIND

$HIND

Biotech is waking up. $XBI has held steady above $105 as investors eye Q4 catalysts — M&A momentum, pivotal trial readouts, and a friendlier rate backdrop. After years of consolidation, sentiment may finally be turning. #Biotech #XBI #LifeSciences #HealthcareInvesting #Biopharma

$HIND

$HIND

Immunoinflammation remains hot! $HIND fiercebiotech.com/biotech/jj-tal…

$HIND

$HIND

$HIND

$HIND

$HIND

$HIND

May this #Deepavali festival of lights remind us that sustained effort, clarity, and purpose ignite the brightest light. Health, wealth & conscious success flow when dedication crosses its threshold of brilliance. Wishing everyone light within and around. #HappyDeepavali

No one should suffer in silence. 💔 Patients with advanced cancer often endure painful, malodorous wounds that affect not just health — but dignity and daily life. Vyome Holdings, Inc. $HIND our investigational program VT-1953 is focused on addressing this urgent unmet need without an FDA

Great analysis The Wall Street Journal. After years of silence, biotech is quietly rallying; and this time it feels real. Valuations are still reasonable; most stocks trade below 2021 peaks. Balance sheets stronger; leaner firms, longer cash runways. Big Pharma is buying again; M&A heating up as

Wow, mRNA vaccines are flipping the script on cancer! #mRNAVaccine #CancerResearch #Immunotherapy Eric Topol

$HIND